Get the Stockscreener App
3.67
3.42%
-0.13
After Hours:
3.72
0.05
+1.36%
Salarius Pharmaceuticals Inc stock is traded at $3.67, with a volume of 173.89K.
It is down -3.42% in the last 24 hours and down -36.28% over the past month.
Salarius Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on developing effective treatments for cancers with high, unmet medical needs. The company has focused on two classes of drugs that address gene dysregulation: targeted protein inhibitors and targeted protein degradation. Its Pipeline includes seclidemstat (SP-2577), a small molecular inhibitor, and SP-3164, a small molecular protein degrader.
See More
Previous Close:
$3.80
Open:
$3.91
24h Volume:
173.89K
Relative Volume:
0.73
Market Cap:
$1.87M
Revenue:
$4.70M
Net Income/Loss:
$-4.99M
P/E Ratio:
-0.5717
EPS:
-6.42
Net Cash Flow:
$-5.29M
1W Performance:
-14.15%
1M Performance:
-36.28%
6M Performance:
-67.55%
1Y Performance:
-83.01%
1-Day Range:
$3.64
$4.0435
1-Week Range:
$3.64
$4.2785
52-Week Range:
$3.64
$108.00
Salarius Pharmaceuticals Inc Stock (SLRX) Company Profile
Name
Salarius Pharmaceuticals Inc
Sector
Industry
Phone
346-772-0346
Address
2450 HOLCOMBE BLVD, HOUSTON
Compare SLRX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SLRX
Salarius Pharmaceuticals Inc
|
3.67 | 3.59M | 4.70M | -4.99M | -5.29M | -6.42 |
|
VRTX
Vertex Pharmaceuticals Inc
|
391.64 | 101.35B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.00 | 58.66B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
562.27 | 59.43B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
737.56 | 44.01B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
340.70 | 36.56B | 3.81B | -644.79M | -669.77M | -6.24 |
Salarius Pharmaceuticals Inc Stock (SLRX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-27-20 | Initiated | Ladenburg Thalmann | Buy |
Salarius Pharmaceuticals Inc Stock (SLRX) Latest News
Can Salarius Pharmaceuticals Inc. stock deliver sustainable ROEMarket Risk Analysis & High Conviction Investment Ideas - newser.com
Should you wait for a breakout in Salarius Pharmaceuticals Inc.Quarterly Profit Summary & High Accuracy Trade Signal Alerts - newser.com
Exit strategy if you’re trapped in Salarius Pharmaceuticals Inc.Portfolio Performance Report & Fast Entry High Yield Tips - newser.com
What momentum shifts mean for Salarius Pharmaceuticals Inc.Earnings Risk Report & Consistent Profit Focused Trading Strategies - newser.com
What Fibonacci levels say about Salarius Pharmaceuticals Inc. reboundJuly 2025 Sentiment & Daily Volume Surge Trade Alerts - newser.com
Is Salarius Pharmaceuticals Inc. (FP10) stock positioned for secular growthEarnings Risk Report & Community Verified Trade Alerts - newser.com
Is Salarius Pharmaceuticals Inc. building a consolidation baseRisk Management & Technical Confirmation Alerts - newser.com
How higher bond yields impact Salarius Pharmaceuticals Inc. (FP10) stockSwing Trade & Real-Time Market Sentiment Reports - newser.com
Risk vs reward if holding onto Salarius Pharmaceuticals Inc.Breakout Watch & Risk Controlled Swing Trade Alerts - newser.com
Salarius Pharmaceuticals Inc Stock Analysis and ForecastStock Price Targets & AI-Based Predictions Available Free - earlytimes.in
What analysts say about Salarius Pharmaceuticals Inc stockContrarian Investment Ideas & Breakthrough Investment Results - earlytimes.in
Why Salarius Pharmaceuticals Inc. (FP10) stock could break out in 2025Weekly Trade Review & Detailed Earnings Play Alerts - newser.com
Tick level data insight on Salarius Pharmaceuticals Inc. volatility2025 Breakouts & Breakdowns & Risk Managed Investment Strategies - newser.com
How to monitor Salarius Pharmaceuticals Inc. with trend dashboardsJuly 2025 Drop Watch & Daily Profit Maximizing Trade Tips - newser.com
Salarius Pharmaceuticals Stock Plummets to 52-Week Low of $4.23 - Markets Mojo
Aug Drivers: Is Redwire Corporation stock undervalued right nowJuly 2025 Closing Moves & Short-Term High Return Ideas - خودرو بانک
Market Fear: Can Salarius Pharmaceuticals Inc outperform under higher oil pricesPortfolio Performance Summary & Weekly Breakout Watchlists - خودرو بانک
Can Salarius Pharmaceuticals Inc. rally from current levelsMarket Rally & Fast Exit Strategy with Risk Control - newser.com
Risk adjusted return profile for Salarius Pharmaceuticals Inc. analyzed2025 Year in Review & Fast Moving Stock Trade Plans - newser.com
Aug Action: What analysts say about Salarius Pharmaceuticals Inc stockDividend Hike & Verified Momentum Watchlists - khodrobank.com
Technical Analysis: Will Salarius Pharmaceuticals Inc outperform tech stocksRate Cut & Daily Entry Point Alerts - خودرو بانک
Salarius Pharmaceuticals Inc Stock (SLRX) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.36%
1.10%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):